Yale School of Medicine Receives $10 Million Donation for Type 1 Diabetes Research
The Yale School of Medicine has secured a $10 million donation from the Bukhman Foundation to fund a five-year research initiative aimed at reversing and potentially curing Type 1 diabetes. The funding, provided by Anastasia and Igor Bukhman, will support a multi-disciplinary team of researchers working to develop precision therapies that prevent or halt the immune system's attack on insulin-producing beta cells. The research program involves several key specialists focusing on personalized treatments based on genetic and immune profiles. Key areas of study include strengthening disease models, analyzing immune cell behavior through cancer immunology insights, enhancing beta cell survival, and utilizing computer modeling to analyze complex immunological data. This initiative seeks to revolutionize diabetes management by moving beyond symptom control toward prevention and reversal.